DE69218932D1 - Transdermale therapeutische Formulierung - Google Patents

Transdermale therapeutische Formulierung

Info

Publication number
DE69218932D1
DE69218932D1 DE69218932T DE69218932T DE69218932D1 DE 69218932 D1 DE69218932 D1 DE 69218932D1 DE 69218932 T DE69218932 T DE 69218932T DE 69218932 T DE69218932 T DE 69218932T DE 69218932 D1 DE69218932 D1 DE 69218932D1
Authority
DE
Germany
Prior art keywords
transdermal therapeutic
therapeutic formulation
formulation
transdermal
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69218932T
Other languages
English (en)
Other versions
DE69218932T2 (de
Inventor
Hideaki Okabe
Ichiro Tsuchida
Takanori Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lintec Corp
Original Assignee
Lintec Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27234515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69218932(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lintec Corp filed Critical Lintec Corp
Application granted granted Critical
Publication of DE69218932D1 publication Critical patent/DE69218932D1/de
Publication of DE69218932T2 publication Critical patent/DE69218932T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
DE69218932T 1991-02-13 1992-08-11 Transdermale therapeutische Formulierung Revoked DE69218932T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3041130A JPH04261119A (ja) 1991-02-13 1991-02-13 経皮吸収型貼付剤
EP92113659A EP0582727B1 (de) 1991-02-13 1992-08-11 Transdermale therapeutische Formulierung
US07/929,044 US5744162A (en) 1991-02-13 1992-08-13 Transdermal therapeutic formulation and a method of administration thereof

Publications (2)

Publication Number Publication Date
DE69218932D1 true DE69218932D1 (de) 1997-05-15
DE69218932T2 DE69218932T2 (de) 1997-07-17

Family

ID=27234515

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69218932T Revoked DE69218932T2 (de) 1991-02-13 1992-08-11 Transdermale therapeutische Formulierung

Country Status (4)

Country Link
US (1) US5744162A (de)
EP (1) EP0582727B1 (de)
JP (1) JPH04261119A (de)
DE (1) DE69218932T2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5962477A (en) 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
AU3512595A (en) * 1994-09-13 1996-03-29 Magainin Pharmaceuticals, Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
IL119417A (en) * 1996-10-13 2003-02-12 Moshe Kushnir Pharmaceutical composition for transdermal administration of levodopa for parkinson's disease
SK284332B6 (sk) * 1996-10-14 2005-01-03 Kowa Company, Ltd. Lokálne anestetikum na vonkajšie použitie
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
US6077527A (en) * 1997-10-28 2000-06-20 National Starch And Chemical Investment Holding Corporation Enhancer tolerant pressure sensitive adhesives for transdermal drug delivery
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE10019311A1 (de) * 2000-04-19 2001-10-31 Lohmann Therapie Syst Lts Transdermale therapuetische Systeme zur Applikation von Moxonidin
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE10224420C1 (de) * 2002-06-01 2003-12-04 Beiersdorf Ag Feucht klebender Wundverband
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
AU2004286232A1 (en) * 2003-10-23 2005-05-12 Alza Corporation Compositions of stabilized DNA for coating microprojections
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
PT1937276E (pt) 2005-10-12 2013-02-21 Besins Healthcare Luxembourg Gel de testosterona melhorado e método para a sua utilização
JP5117709B2 (ja) * 2006-12-04 2013-01-16 リンテック株式会社 紫外線照射装置及び紫外線照射方法
CA2738524C (en) 2008-10-02 2013-11-26 Mylan Inc. Method for making a multilayer adhesive laminate
ITMI20111355A1 (it) 2011-07-20 2013-01-21 Epifarma Srl Cerotto transdermico contenente diclofenac e tiocolchicoside
JP5766379B1 (ja) * 2013-12-24 2015-08-19 株式会社グリーンエバー サルファ剤およびキトサン剤を含み、剤型が散剤である、ゲル形成剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
JPS61502760A (ja) * 1984-07-24 1986-11-27 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 粘着性経皮投与層
CA1299319C (en) * 1986-10-23 1992-04-21 Izumi Saitoh Acrylic copolymer and skin protective
US4789547A (en) * 1987-06-17 1988-12-06 Warner-Lambert Company Transdermal matrix system
DE3924393A1 (de) * 1989-07-24 1991-01-31 Roehm Gmbh Wasserloeslicher druckempfindlicher hauthaftkleber, dessen verwendung und damit ausgeruestete mittel

Also Published As

Publication number Publication date
DE69218932T2 (de) 1997-07-17
EP0582727A1 (de) 1994-02-16
EP0582727B1 (de) 1997-04-09
JPH04261119A (ja) 1992-09-17
US5744162A (en) 1998-04-28

Similar Documents

Publication Publication Date Title
DE69218932D1 (de) Transdermale therapeutische Formulierung
FI934914A (fi) Farmaceutiska formuleringar
FI921598A (fi) Transdermal komposition
PT101106A (pt) Dispositivo administrador
DE69210290D1 (de) Behandlungsvorrichtung
DK0609594T3 (da) Elektroterapiindretning
NO923859D0 (no) Medikament
DE69215919D1 (de) Medizinisches Gerät
DK0507513T3 (da) Terapeutisk anordning
FI922238A (fi) Stoed foer terapeutisk magnet
DE69217181D1 (de) Spieleinstellvorrichtung
NO922521D0 (no) Piperidinyletanolderivater med terapeutisk virkning
FI930674A0 (fi) Terapeutiska aemnen
BG96715A (bg) Терапевтични вещества
DK0511991T3 (da) Farmaceutisk formulering
FI931071A0 (fi) Terapeutiska aemnen
PT100435A (pt) Nucleosidos terapeuticos
DK0663831T3 (da) Transdermal azidothymidin
FI920701A (fi) Anordning foer terapeutisk tryckbehandling
DK429589A (da) Transdermalt laegemiddelpraeparat
KR920014763U (ko) 지압의자
DK85290A (da) Terapeutisk virksomme forbindelser
NO923082D0 (no) Terapeutiske midler
FI981925A0 (fi) Medetomidiinia sisältävät valmisteet transdermaalista antoa varten
KR930006250U (ko) 지압기

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation